Insider Trading Activity For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
Reeve B. Waud , Director of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reportedly Sold 1,240,000 shares of the company’s stock at an average price of 51.72 for a total transaction amount of $64,132,800.00 SEC Form
Insider Trading History For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
Analyst Ratings For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
These are 3 Hold Ratings, 9 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is Buy (Score: 2.85) with a consensus target price of $59.67 , a potential (14.55% upside)
Analyst Ratings History For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
- On 2/17/2016 Avondale Partners Lower Price Target of rating Market Outperform with a price target of $90.00 to $71.00
- On 2/18/2016 Susquehanna Bancshares Inc Lower Price Target of rating Positive with a price target of $92.00 to $75.00
- On 2/20/2016 Stephens Reiterated Rating Buy
- On 9/15/2016 Robert W. Baird Lower Price Target of rating Outperform with a price target of $67.00 to $66.00
- On 9/27/2016 J P Morgan Chase & Co Reiterated Rating Hold with a price target of $61.00
- On 11/3/2016 Raymond James Financial, Inc. Upgraded rating Outperform to Strong-Buy with a price target of $65.00
- On 1/3/2017 Royal Bank of Canada Reiterated Rating Buy with a price target of $56.00
Recent Trading Activity for Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
Shares of Acadia Healthcare Company, Inc. closed the previous trading session at 52.09 down -0.84 -1.59% with 2,244,565 shares trading hands.